PATENT CLAIM ANALYSIS

Application Number: 16130079
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-08
Patent Classification: ["514", "316000"]

Abstract:
The invention provides two crystalline freebase forms of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester. The invention also provides pharmaceutical compositions comprising the crystalline freebase or prepared using the crystalline freebases; processes and intermediates for preparing the crystalline freebases; and methods of using the crystalline freebases to treat a pulmonary disorder.

Claim (Index 22):
A crystalline freebase of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester having a differential scanning calorimetry thermogram substantially in accordance with that shown in  FIG. 4 .

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.42553
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14547455', '15677264', '12835964', '14955515', '15206877']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8032393085807109
- 35 USC 102 Novelty (BERT): 0.5527668172275807
- Combined Prediction Score: 0.7781920594453979
- Mean Citation Score: 405.408388
- Max Citation Score: 405.44687000000016
- Similarity Product: 315.99027943650907

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test